Systematic review / meta-analysis / 2014
Peppermint oil was significantly more effective than placebo for global IBS symptom improvement and abdominal pain relief.
A systematic review and meta-analysis assessed the efficacy and safety of enteric-coated peppermint oil capsules versus placebo for active irritable bowel syndrome across 9 randomized trials with 726 patients. Peppermint oil was significantly superior to placebo for global symptom improvement (5 studies, 392 patients, RR 2.23; 95% CI, 1.78-2.81) and abdominal pain improvement (5 studies, 357 patients, RR 2.14; 95% CI, 1.64-2.79). Patients receiving peppermint oil were significantly more likely to experience adverse events, though these were mild and transient, with heartburn being the most common.
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- 726 patients with active irritable bowel syndrome across 9 studies
- What was measured
- Global improvement of IBS symptoms, improvement in abdominal pain, and adverse events
THE PAPER
Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis.
Khanna R, MacDonald JK, Levesque BG. J Clin Gastroenterol, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.